Shire Pursues FDA Approval for Plasma Manufacturing Facility

Shire said today it is pursuing FDA approval for a new plasma manufacturing facility within its Covington, GA, campus that is expected to boost the site’s production capacity by approximately 30%.“The additional capacity from this site is a key element to support the growth in our immunology franchise,” Matt Walker, Shire’s head of technical operations, said in a statement.Immunology is one of Shire’s seven therapeutic areas, generating $1.516 billion of Shire&rsquo